(Q39224836)

10 September 2017

title

Switching from high-dose clopidogrel to prasugrel in ACS patients undergoing PCI: a single-center experience (English)

1 reference

10 September 2017

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24659130%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Paolo Marino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24659130%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

4

Harry Suryapranata

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24659130%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Giuseppe De Luca

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24659130%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Monica Verdoia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24659130%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Alon Schaffer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24659130%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

David Antoniucci

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24659130%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

1 October 2014

1 reference

Journal of Thrombosis and Thrombolysis

10 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24659130%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24659130%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24659130%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

388-394

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24659130%20AND%20SRC:MED&resulttype=core&format=json

Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

A meta-analytic overview of thrombectomy during primary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myoc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Bivalirudin for patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Clinical end points in coronary stent trials: a case for standardized definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Safety of reloading prasugrel in addition to clopidogrel loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

Time course, predictors and clinical implications of stent thrombosis following primary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1039-0

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24659130

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Safety and benefits of protamine administration to revert anticoagulation soon after coronary angioplasty. A meta-analysis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24659130

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24659130